Vystar Corp: directors' dealings · United States · SEC (Form 4)

About Vystar Corp

Vystar Corp. is a U.S.-listed company trading on the OTCQB market, not on NYSE/NASDAQ at this stage. For international investors, it should be viewed as a small-cap American company with a mixed profile: a legacy industrial/materials business built around natural rubber latex, alongside more recent strategic moves into digital finance and tokenization. Founded in 2001, Vystar initially developed its core thesis around Vytex®, an ultra-low-protein natural rubber latex designed to reduce antigenic and total proteins versus conventional latex. The company positions this technology as a cleaner raw material for products used in healthcare, consumer goods, adhesives, foams, textiles, coatings, and related applications. ([vystarcorp.com](https://vystarcorp.com/company-home/?utm_source=openai)) Vystar describes itself as the owner and manufacturer of multiple eco-friendly brands serving home, office, and medical markets. Its portfolio includes Vytex, as well as legacy operating assets such as Fluid Energy Conversion (FEC) and RXAIR. The company also highlights consumer-oriented uses of its technology, including bedding-related products such as mattresses, toppers, and pillows, which broadens the story beyond a pure industrial materials supplier. From a geographic standpoint, Vystar has historically emphasized international distribution and partnerships, including reach into North America and Europe, and references a global footprint for some of its latex-related products. ([vystarcorp.com](https://vystarcorp.com/company-home/?utm_source=openai)) On competitive positioning, Vystar is best understood as a niche specialty player rather than a scale leader. Its potential moat rests on product differentiation: Vytex is presented as a technically improved natural latex alternative with lower protein content and reduced impurity levels, which may be relevant in sensitive use cases such as medical and hygiene products. However, the company operates in markets where larger, better-capitalized competitors dominate procurement, distribution, manufacturing, and branding. As a result, the investment case is less about current market share and more about whether Vystar can monetize its intellectual property and niche brand portfolio in a sustainable way. ([vystarcorp.com](https://vystarcorp.com/company-home/?utm_source=openai)) Recent developments point to a more pronounced strategic pivot. In April 2026, Vystar announced a binding letter of intent to acquire a 50% interest in R3alm, a compliance-focused AI/Web3 financial ecosystem centered on tokenized assets, digital capital formation, and trading infrastructure. Shortly afterward, Vystar said it was concentrating most of its resources on R3alm while also planning a dividend spin-off of RXAIR and related brands. That sequence suggests a company in transition, balancing industrial legacy assets with a higher-risk fintech and digital-asset initiative. For investors, the key takeaway is that Vystar remains an evolving U.S. micro-cap story with exposure to materials, healthcare-adjacent products, consumer brands, and emerging digital finance themes, all within the United States-listed market structure. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/04/20/3277127/0/en/vystar-enters-into-binding-letter-of-intent-to-acquire-50-interest-in-r3alm-inc.html?utm_source=openai))